Does anti-nerve growth factor monoclonal antibody treatment have the potential to replace nonsteroidal anti-inflammatory drugs and opioids in treating hip or knee osteoarthritis? A systematic review of randomized controlled trials

PURPOSE: Considering the adverse effects of nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids for treating osteoarthritis (OA), development of drugs that are more effective and better tolerated than existing treatments is urgently needed. This systematic review aimed to evaluate the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Di, Zeng, Ling-feng, Liang, Gui-hong, Pan, Jian-ke, Luo, Ming-hui, Han, Yan-hong, Liu, Jun, Yang, Wei-yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
General Orthopaedics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297056/
https://www.ncbi.nlm.nih.gov/pubmed/35900204
http://dx.doi.org/10.1530/EOR-21-0103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297056/
https://www.ncbi.nlm.nih.gov/pubmed/35900204
http://dx.doi.org/10.1530/EOR-21-0103

Ejemplares similares